AUGUST 12 - 14, 2020
AUGUST 15, 2020 Optional WORKSHOPS


Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and Global Academy for Medical Education. Postgraduate Institute for Medicine is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

The American Board of Psychiatry and Neurology has reviewed the Current Psychiatry/AACP 2020 Focus on Neuropsychiatry and has approved this program as part of a comprehensive CME program, which is mandated by the ABPN as a necessary component of maintenance of certification (MOC). The activity awards 18 AMA PRA Category 1 Credits™ (including pre-conference workshops) and 8 Self-Assessment Category 1 CME credits.

Target Audience:

This activity is designed for neuropsychiatrists, child and general psychiatrists, adolescent psychiatrists, geriatric psychiatrists, nurse practitioners, physician assistants, nurses, psychologists, social workers, and other mental health professionals interested in treating patients with
neuropsychiatric disorders.

Physician Continuing Medical Education:

The Postgraduate Institute for Medicine designates this live activity for a maximum of 18 AMA PRA Category 1 Credits™ (13 for the general sessions and 5 for attending the pre-conference workshops). Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 18 (13 for the general sessions and 5 for attending the pre-conference workshops) contact hours. Pharmacotherapy contact hours for Advance Practice Registered Nurses to be determined and will
be indicated on your certificate.

Follow Us